Journal
IMMUNOLOGIC RESEARCH
Volume 39, Issue 1-3, Pages 271-278Publisher
HUMANA PRESS INC
DOI: 10.1007/s12026-007-0073-4
Keywords
antibody dependent cellular cytotoxicity (ADCC); complement; immunotherapy; lymphoma; breast cancer; signaling induced apoptosis
Categories
Ask authors/readers for more resources
Monoclonal antibodies (mAbs) are used extensively as treatment for cancer. A variety of mechanisms are thought to play important roles in mediating the observed antitumor effects of mAb. These include signaling mediated by cross-linking of surface antigen that leads to cell death, blocking an activation signal that is necessary for continued cell growth, antibody-dependent cellular cytotoxicity (ADCC), complement mediated cytotoxicity (CMC) and the ability of mAb to alter the cytokine milieu or enhance development of an active anti-tumor immune response. In this review the in vitro, animal model and clinical results supporting each of these varied mechanisms is summarized as is the potential for these mechanisms to interact with each other.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available